Radiomics Predicts High or Low Recurrence Risk and is Associated with LncRNAs in Breast Cancer

The key radiomic features were found to vary after neoadjuvant chemotherapy. Moreover, lncRNAs were discovered to be significantly correlated with radiomics and recurrence-free survival (RFS). The findings indicate that the radiomic signature can be conveniently used for individualized prediction of RFS and that radiomics is associated with lncRNAs in breast cancer. Total RNA-seq profiles of breast cancer patients